Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

1,134

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

January 6, 2020

Study Completion Date

August 10, 2021

Conditions
Enterovirus InfectionsInfluenza
Interventions
BIOLOGICAL

EV71 vaccine and influenza vaccine

simultaneously administrated with EV71 vaccine and influenza vaccine

BIOLOGICAL

EV71 vaccine

administrated with EV71 vaccine only

BIOLOGICAL

influenza vaccine

administrated with influenza vaccine only

Trial Locations (1)

310051

Zhejiang provincial center for disease control and prevention, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

collaborator

Henan Center for Disease Control and Prevention

OTHER_GOV

collaborator

Guizhou Center for Disease Control and Prevention

OTHER

collaborator

Wuhan Institute of Biological Products Co., Ltd

INDUSTRY

collaborator

Changchun Institute of Biological Products Co., Ltd.

INDUSTRY

collaborator

Peking University

OTHER

collaborator

National Institutes for Food and Drug Control, China

OTHER

lead

China National Biotec Group Company Limited

INDUSTRY

NCT04091880 - Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine | Biotech Hunter | Biotech Hunter